- Home
- UUU vs BIAF Comparison
UUU vs BIAF Comparison
Compare UUU & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UUU
- BIAF
- Stock Information
- Founded
- UUU 1969
- BIAF 2014
- Country
- UUU United States
- BIAF United States
- Employees
- UUU N/A
- BIAF N/A
- Industry
- UUU Electronic Components
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- UUU Technology
- BIAF Health Care
- Exchange
- UUU Nasdaq
- BIAF Nasdaq
- Market Cap
- UUU 8.3M
- BIAF 7.6M
- IPO Year
- UUU N/A
- BIAF 2022
- Fundamental
- Price
- UUU $5.70
- BIAF $0.16
- Analyst Decision
- UUU
- BIAF Hold
- Analyst Count
- UUU 0
- BIAF 1
- Target Price
- UUU N/A
- BIAF N/A
- AVG Volume (30 Days)
- UUU 3.7M
- BIAF 12.0M
- Earning Date
- UUU 08-19-2025
- BIAF 11-13-2025
- Dividend Yield
- UUU 15.80%
- BIAF N/A
- EPS Growth
- UUU N/A
- BIAF N/A
- EPS
- UUU 1.19
- BIAF N/A
- Revenue
- UUU $22,789,285.00
- BIAF $7,681,059.00
- Revenue This Year
- UUU N/A
- BIAF N/A
- Revenue Next Year
- UUU N/A
- BIAF $20.04
- P/E Ratio
- UUU $5.49
- BIAF N/A
- Revenue Growth
- UUU 30.84
- BIAF 4.99
- 52 Week Low
- UUU $1.11
- BIAF $0.16
- 52 Week High
- UUU $8.27
- BIAF $2.26
- Technical
- Relative Strength Index (RSI)
- UUU 55.01
- BIAF 34.12
- Support Level
- UUU $4.78
- BIAF $0.24
- Resistance Level
- UUU $6.82
- BIAF $0.45
- Average True Range (ATR)
- UUU 0.96
- BIAF 0.03
- MACD
- UUU -0.01
- BIAF -0.01
- Stochastic Oscillator
- UUU 49.32
- BIAF 7.50
About UUU Universal Security Instruments Inc.
Universal Safety Products Inc is a U.S.-based importer and distributor of home safety devices such as ventilation fans and ground fault circuit interrupters.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.